Mats Andersson

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Dominique Baeten, Joachim Sieper, Jürgen Braun et al. · New England Journal of Medicine · 2015 · 973 citations · Full text

Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance

Mats Andersson · Cell · 1985 · 323 citations

Vaccination, Possible Means, Viral Pathogenesis +8

Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study

Oluf Andersen, Per-Erik Lygner, T. Bergstr�m et al. · Journal of Neurology · 1993 · 266 citations

Viral Persistence, Disease Progression, Multiple Sclerosis Relapses +9

Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3

Karel Pavelka, Alan Kivitz, Eva Dokoupilová et al. · Arthritis Research & Therapy · 2017 · 227 citations · Full text

Treatment of Growth Hormone-Deficient Adults with Recombinant Human Growth Hormone Increases the Concentration of Growth Hormone in the Cerebrospinal Fluid and Affects Neurotransmitters

Göran Larson, Mats Andersson, Anders Elmgren et al. · Neuroendocrinology · 1995 · 205 citations